SOLENO THERAPEUT. DL-001 (6XC) — Working Capital to Net Assets Ratio
SOLENO THERAPEUT. DL-001 (6XC) has a Working Capital to Net Assets ratio of 65.4% as of December 2025. Working capital of €294.45 Million (current assets of €355.81 Million minus current liabilities of €61.36 Million) is measured against net assets of €450.12 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See SOLENO THERAPEUT. DL-001 (6XC) financial flexibility to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
SOLENO THERAPEUT. DL-001 Working Capital to Net Assets (2021–2025)
This chart shows how SOLENO THERAPEUT. DL-001's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 65.4%, reflecting working capital of €294.45 Million against net assets of €450.12 Million EUR. See SOLENO THERAPEUT. DL-001 defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for SOLENO THERAPEUT. DL-001 (2021–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for SOLENO THERAPEUT. DL-001 from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see SOLENO THERAPEUT. DL-001 stock valuation.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 65.4% | €294.45 Million | €450.12 Million | €355.81 Million | €61.36 Million | ▼ -46.8 pp |
| 2024 | 112.3% | €275.14 Million | €245.11 Million | €293.89 Million | €18.75 Million | ▲ +10.8 pp |
| 2023 | 101.5% | €159.85 Million | €157.51 Million | €171.36 Million | €11.51 Million | ▲ +21.0 pp |
| 2022 | 80.5% | €8.33 Million | €10.35 Million | €15.65 Million | €7.31 Million | ▼ -0.5 pp |
| 2021 | 81.0% | €14.41 Million | €17.79 Million | €22.42 Million | €8.01 Million | — |